Perinatal tuberculosis—An approach to an under-recognized diagnosis

Tuberculosis (TB) in young infants (<3 months of age), often referred to as perinatal TB, is underdiagnosed, leading to severe morbidity and high mortality. Perinatal TB includes both congenital and postnatal transmission of Mycobacterium tuberculosis. We aimed to increase an awareness of TB...

Full description

Bibliographic Details
Main Authors: H. Simon Schaaf, Adrie Bekker, Helena Rabie
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2023.1239734/full
_version_ 1797635124699856896
author H. Simon Schaaf
Adrie Bekker
Helena Rabie
author_facet H. Simon Schaaf
Adrie Bekker
Helena Rabie
author_sort H. Simon Schaaf
collection DOAJ
description Tuberculosis (TB) in young infants (<3 months of age), often referred to as perinatal TB, is underdiagnosed, leading to severe morbidity and high mortality. Perinatal TB includes both congenital and postnatal transmission of Mycobacterium tuberculosis. We aimed to increase an awareness of TB in neonates and young infants and to provide guidance on the assessment and management when in contact with mothers with TB during or soon after pregnancy. Approximately 217,000 pregnant women develop TB annually; if they are not diagnosed and treated during pregnancy, their infants are at high risk of adverse birth outcomes and TB disease. Although safe and effective antituberculosis treatment regimens are available during pregnancy, the diagnosis of TB is challenging. Infants born to mothers newly diagnosed with TB, not receiving any effective treatment or with cultures not yet negative, should be assessed for TB disease or M. tuberculosis infection. TB preventive therapy should be instituted if the infant is clinically well but exposed to TB, while prompt initiation of TB treatment is essential if TB disease is presumed. HIV status of mother and infant should be considered as this will affect the management. Further research is needed for the diagnosis and prevention of TB during pregnancy, an early diagnosis of TB in infants, and antituberculosis drug pharmacokinetics in young infants.
first_indexed 2024-03-11T12:17:50Z
format Article
id doaj.art-9efdb59cb1bc4f9f85596d7a1cebad0c
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-03-11T12:17:50Z
publishDate 2023-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-9efdb59cb1bc4f9f85596d7a1cebad0c2023-11-07T07:21:31ZengFrontiers Media S.A.Frontiers in Public Health2296-25652023-11-011110.3389/fpubh.2023.12397341239734Perinatal tuberculosis—An approach to an under-recognized diagnosisH. Simon Schaaf0Adrie Bekker1Helena Rabie2Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaDepartment of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaDepartment of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaTuberculosis (TB) in young infants (<3 months of age), often referred to as perinatal TB, is underdiagnosed, leading to severe morbidity and high mortality. Perinatal TB includes both congenital and postnatal transmission of Mycobacterium tuberculosis. We aimed to increase an awareness of TB in neonates and young infants and to provide guidance on the assessment and management when in contact with mothers with TB during or soon after pregnancy. Approximately 217,000 pregnant women develop TB annually; if they are not diagnosed and treated during pregnancy, their infants are at high risk of adverse birth outcomes and TB disease. Although safe and effective antituberculosis treatment regimens are available during pregnancy, the diagnosis of TB is challenging. Infants born to mothers newly diagnosed with TB, not receiving any effective treatment or with cultures not yet negative, should be assessed for TB disease or M. tuberculosis infection. TB preventive therapy should be instituted if the infant is clinically well but exposed to TB, while prompt initiation of TB treatment is essential if TB disease is presumed. HIV status of mother and infant should be considered as this will affect the management. Further research is needed for the diagnosis and prevention of TB during pregnancy, an early diagnosis of TB in infants, and antituberculosis drug pharmacokinetics in young infants.https://www.frontiersin.org/articles/10.3389/fpubh.2023.1239734/fulltuberculosisperinatalcongenitalpostnatalpreventiondiagnosis
spellingShingle H. Simon Schaaf
Adrie Bekker
Helena Rabie
Perinatal tuberculosis—An approach to an under-recognized diagnosis
Frontiers in Public Health
tuberculosis
perinatal
congenital
postnatal
prevention
diagnosis
title Perinatal tuberculosis—An approach to an under-recognized diagnosis
title_full Perinatal tuberculosis—An approach to an under-recognized diagnosis
title_fullStr Perinatal tuberculosis—An approach to an under-recognized diagnosis
title_full_unstemmed Perinatal tuberculosis—An approach to an under-recognized diagnosis
title_short Perinatal tuberculosis—An approach to an under-recognized diagnosis
title_sort perinatal tuberculosis an approach to an under recognized diagnosis
topic tuberculosis
perinatal
congenital
postnatal
prevention
diagnosis
url https://www.frontiersin.org/articles/10.3389/fpubh.2023.1239734/full
work_keys_str_mv AT hsimonschaaf perinataltuberculosisanapproachtoanunderrecognizeddiagnosis
AT adriebekker perinataltuberculosisanapproachtoanunderrecognizeddiagnosis
AT helenarabie perinataltuberculosisanapproachtoanunderrecognizeddiagnosis